SSII Quote, Financials, Valuation and Earnings

Intuitive Surgical, Inc. has a net margin of -29.04% compared to SS Innovations International, Inc.'s net margin of 28.31%. SS Innovations International, Inc.'s return on equity of -38.71% beat Intuitive Surgical, Inc.'s return on equity of 16.38%.

SS Innovations International, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $599.60 which suggests that it could grow by 3.77%. Given that Intuitive Surgical, Inc. has higher upside potential than SS Innovations International, Inc., analysts believe Intuitive Surgical, Inc. is more attractive than SS Innovations International, Inc..

SS Innovations International, Inc. has a beta of -78.180, which suggesting that the stock is 7917.957% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.249%.

SS Innovations International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SS Innovations International, Inc. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.

SS Innovations International, Inc. quarterly revenues are $12.8M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.5B. SS Innovations International, Inc.'s net income of -$3.7M is lower than Intuitive Surgical, Inc.'s net income of $709.2M. Notably, SS Innovations International, Inc.'s price-to-earnings ratio is -- while Intuitive Surgical, Inc.'s PE ratio is 76.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SS Innovations International, Inc. is 29.41x versus 21.86x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -29.04% compared to SS Innovations International, Inc.'s net margin of -862.39%. SS Innovations International, Inc.'s return on equity of -38.71% beat VolitionRX Ltd.'s return on equity of --.

SS Innovations International, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 780%. Given that VolitionRX Ltd. has higher upside potential than SS Innovations International, Inc., analysts believe VolitionRX Ltd. is more attractive than SS Innovations International, Inc..

SS Innovations International, Inc. has a beta of -78.180, which suggesting that the stock is 7917.957% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

SS Innovations International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SS Innovations International, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

SS Innovations International, Inc. quarterly revenues are $12.8M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. SS Innovations International, Inc.'s net income of -$3.7M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, SS Innovations International, Inc.'s price-to-earnings ratio is -- while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SS Innovations International, Inc. is 29.41x versus 17.13x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision, Inc. has a net margin of -29.04% compared to SS Innovations International, Inc.'s net margin of -1037.17%. SS Innovations International, Inc.'s return on equity of -38.71% beat Catheter Precision, Inc.'s return on equity of -192.05%.

SS Innovations International, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 2161.97%. Given that Catheter Precision, Inc. has higher upside potential than SS Innovations International, Inc., analysts believe Catheter Precision, Inc. is more attractive than SS Innovations International, Inc..

SS Innovations International, Inc. has a beta of -78.180, which suggesting that the stock is 7917.957% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.

SS Innovations International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SS Innovations International, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.

SS Innovations International, Inc. quarterly revenues are $12.8M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. SS Innovations International, Inc.'s net income of -$3.7M is lower than Catheter Precision, Inc.'s net income of -$2.3M. Notably, SS Innovations International, Inc.'s price-to-earnings ratio is -- while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SS Innovations International, Inc. is 29.41x versus 7.90x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -29.04% compared to SS Innovations International, Inc.'s net margin of 3.93%. SS Innovations International, Inc.'s return on equity of -38.71% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

SS Innovations International, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 93.3%. Given that Xtant Medical Holdings, Inc. has higher upside potential than SS Innovations International, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than SS Innovations International, Inc..

SS Innovations International, Inc. has a beta of -78.180, which suggesting that the stock is 7917.957% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

SS Innovations International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SS Innovations International, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

SS Innovations International, Inc. quarterly revenues are $12.8M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. SS Innovations International, Inc.'s net income of -$3.7M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, SS Innovations International, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 76.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SS Innovations International, Inc. is 29.41x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.